一名患有罕见癌症的11岁的澳大利亚男孩于2025年3月死亡,留下遗产,用于推进非侵入性儿科癌症检测。 An 11-year-old Australian boy with rare cancer died in March 2025, leaving a legacy to advance non-invasive pediatric cancer testing.

11岁的来自悉尼的Beau Hewitt在经历疲劳、体重减退和疼痛后,被诊断为罕见的临床肿瘤。 Eleven-year-old Beau Hewitt from Sydney was diagnosed with rare myoepithelial carcinoma after experiencing fatigue, weight loss, and pain. 尽管治疗了一年,但癌症在2024年底蔓延,导致他的家庭将重点放在生活质量上,享受钓鱼和步行。 Despite a year of treatment, cancer spread by late 2024, leading his family to focus on quality of life, enjoying fishing and footy. Beau于2025年3月18日去世, 就在他13岁生日前, 将积蓄留给弟弟, Beau died on March 18, 2025, just before his 13th birthday, and left his savings to his brother while urging his family to fight for other children. 他的父母现在支持儿童癌症研究所的圣诞呼吁, 主张让更多人有机会使用液体生物心理 — — 一种在血液中检测癌症DNA的非侵入性检测 — — 希望它成为儿科护理的标准。 His parents now support the Children’s Cancer Institute’s Christmas appeal, advocating for wider access to liquid biopsy—a non-invasive test detecting cancer DNA in blood—hoping it becomes standard in pediatric care.